FindTrial
Sign In

To compare Clinical efficacy of ropivacaine 0.75% vs lignocaine hydrochloride 2% with adrenaline (1:80,000) in patients undergoing removal of bilateral maxillary third molars.

Clinical efficacy of ropivacaine 0.75% vs lignocaine hydrochloride 2% with adrenaline (1:80,000) in patients undergoing removal of bilateral maxillary third molars using posterior superior alveolar nerve block technique.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019653
Enrollment
50
Registered
2019-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: ROPIVACAINE 0.75%: LOCAL ANESTHETIC AGENT Control Intervention1: LIGNOCAINE HYDROCHLORIDE 2% WITH ADRENALINE(1:80000): LOCAL ANESTHETIC AGENT

Sponsors

Aniket Narayan Kakade
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy Patients requiring removal of bilateral maxillary third molars. 2. Age group: 20-50 years. 3. Patients willing to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patient allergic to amide type of local anaesthetic agents 2. Patient having any systemic disease (cardiovascular disease, hypertension, anxious patients etc.) 3. Pregnant and lactating mothers 4. Patients who are mentally challenged or unable to communicate.

Design outcomes

Primary

MeasureTime frame
I. Onset of anaesthesia II. Intensity of Pain during the extraction III. Need for additional anaesthesia IV. Blood pressure on right brachial artery in semi-reclined position V. Heart rate in semi-reclined positionTimepoint: 15 mins before the anaesthesia, 15 mins after the anaesthesia and after the completion of extraction.—

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE—

Countries

India

Contacts

Public ContactDr Sanjay Joshi

Terna Dental college

sanjoshi99@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026